MANGROVE PARTNERS IM, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001535392
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2024 · 153 positions · Total reported value $890.05M · Top-10 concentration 40.9% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 69.6% · 143 new · 48 cut · 205 exited
Active Share (vs S&P 500): 99.2% · vs QQQ: 99.6% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -8.2% · vs SPY -10.3% · Prev Value $1.52B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +4.0% · vs SPY +1.8% · Latest Value $1.47B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2024 13F filing, MANGROVE PARTNERS IM, LLC disclosed 153 equity positions with a combined reported value of $890.05M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.9% of reported value. HoldingsHub classifies the profile as Small / High Turnover.
The largest disclosed positions as of Q4 2024 were LLYVK ($43.29M), ATMU ($43.08M), TEVA ($42.59M). By sector, the heaviest allocations are Consumer Discretionary 25.8%, Health Care 16.5%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+6.0pp), Materials (+2.7pp) and away from Financials (-1.0pp), Technology (-1.8pp).
Versus the prior quarter, MANGROVE PARTNERS IM, LLC opened 143 new positions, trimmed 48 and fully exited 205, a turnover rate of 69.6% of positions. The portfolio's overlap with the prior quarter was 35% of names.
The largest new positions opened in Q4 2024 were TIGO ($6.84M), SIMO ($5.13M), CHARU ($3.72M).
Of the 205 positions fully exited versus the prior quarter, the largest were JXN ($37.46M), JOYY ($37.20M), ANAB ($23.10M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2024)
- TIGO MILLICOM INTL CELLULAR S A · $6.84M
- SIMO SILICON MOTION TECHNOLOGY CO · $5.13M
- CHARU CHARLTON ARIA ACQUISITION CO · $3.72M
- ANEB ANEBULO PHARMACEUTICALS INC · $3.64M
- NOEMU CO2 ENERGY TRANSITION CORP · $2.91M
- CHEB CHENGHE ACQUISITION II CO · $2.00M
- AAP ADVANCE AUTO PARTS INC · $1.96M
- VVV VALVOLINE INC · $1.70M
Fully Exited (vs previous quarter)
- JXN JACKSON FINANCIAL INC · prev qtr: $37.46M
- JOYY JOYY INC · prev qtr: $37.20M
- ANAB ANAPTYSBIO INC · prev qtr: $23.10M
- IBIT ISHARES BITCOIN TRUST ETF · prev qtr: $15.69M
- INDV INDIVIOR PHARMACEUTICALS INC · prev qtr: $11.27M · history
- GLLIW GLOBALINK INVESTMENT -CW23 · prev qtr: $10.77M
- YOTAW Yotta Acquisition Corp · prev qtr: $10.00M
- DUETW DUET ACQUISITION CORP · prev qtr: $8.45M
Insider Transactions (Form 4)
Latest MANGROVE PARTNERS IM, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Mangrove Partners IM is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 426 US equity positions with a combined value of $1.52B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: GREENWICH, CT, United States
- SEC registration: 801-78070 (status: Approved), registered 2013-05-20
- Regulatory AUM (Form ADV): $2.71B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
- Website: mangrovepartners.com
Portfolio Structure
- 426 positions · $1.52B reported value (Q2 2026)
- Top 10 holdings = 38.1% of reported value
- Largest position: INDV (INDIVIOR PHARMACEUTICALS INC) at 7.2%
- Average position size: $3.57M
Sector Tilt
- Consumer Discretionary 20.8%
- Financials 18.5%
- Information Technology 13.9%
- (classified holdings cover 89% of value)
Quarterly Activity
- Q2 2026: 198 new, 40 added, 61 reduced, 199 exited
- 127 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
636.12K | $43.29M | 4.86% | Hold | |
| 2 |
|
1.10M | $43.08M | 4.84% | Reduce | |
| 3 |
|
1.93M | $42.59M | 4.79% | Reduce | |
| 4 |
|
415.16K | $39.81M | 4.47% | Reduce | |
| 5 |
|
506.78K | $37.89M | 4.26% | Reduce | |
| 6 |
|
1.93M | $35.32M | 3.97% | Reduce | |
| 7 |
|
340.90K | $32.62M | 3.67% | Reduce | |
| 8 |
|
2.17M | $31.70M | 3.56% | Reduce | |
| 9 |
|
8.64M | $30.23M | 3.40% | Reduce | |
| 10 |
|
531.30K | $27.37M | 3.08% | Reduce | |
| 11 |
|
844.14K | $26.86M | 3.02% | Reduce | |
| 12 |
|
352.85K | $26.74M | 3.00% | Reduce | |
| 13 |
|
223.30K | $25.73M | 2.89% | Hold | |
| 14 |
|
1.40M | $24.65M | 2.77% | Reduce | |
| 15 |
|
1.06M | $19.13M | 2.15% | Reduce | |
| 16 |
|
2.82M | $17.73M | 1.99% | Hold | |
| 17 |
|
377.91K | $16.72M | 1.88% | Reduce | |
| 18 |
|
493.06K | $16.30M | 1.83% | Hold | |
| 19 |
|
286.89K | $16.26M | 1.83% | Reduce | |
| 20 |
|
527.64K | $16.00M | 1.80% | Reduce | |
| 21 |
|
175.24K | $15.68M | 1.76% | Reduce | |
| 22 |
|
395.38K | $15.26M | 1.72% | Reduce | |
| 23 |
|
249.49K | $14.67M | 1.65% | Hold | |
| 24 |
|
338.64K | $14.61M | 1.64% | Hold | |
| 25 |
|
736.38K | $11.66M | 1.31% | Add | |
| 26 |
|
950.10K | $10.90M | 1.22% | Hold | |
| 27 |
|
896.70K | $10.76M | 1.21% | Hold | |
| 28 |
|
793.19K | $9.63M | 1.08% | Reduce | |
| 29 |
|
681.03K | $8.68M | 0.97% | Hold | |
| 30 |
|
1.23M | $8.31M | 0.93% | Hold | |
| 31 |
|
4.60M | $8.14M | 0.92% | Hold | |
| 32 |
|
1.38M | $8.06M | 0.91% | Hold | |
| 33 |
|
650.00K | $7.66M | 0.86% | Hold | |
| 34 |
|
625.00K | $7.30M | 0.82% | Hold | |
| 35 |
|
607.68K | $6.88M | 0.77% | Hold | |
| 36 |
|
273.46K | $6.84M | 0.77% | New | |
| 37 |
|
1.33M | $6.81M | 0.77% | Hold | |
| 38 |
|
500.03K | $6.47M | 0.73% | Hold | |
| 39 |
|
99.26K | $5.97M | 0.67% | Hold | |
| 40 |
|
482.59K | $5.95M | 0.67% | Hold | |
| 41 |
|
525.09K | $5.88M | 0.66% | Hold | |
| 42 |
|
5.02M | $5.78M | 0.65% | Reduce | |
| 43 |
|
288.18K | $5.75M | 0.65% | Reduce | |
| 44 |
|
95.00K | $5.13M | 0.58% | New | |
| 45 |
|
450.00K | $4.56M | 0.51% | Hold | |
| 46 |
|
262.36K | $4.07M | 0.46% | Reduce | |
| 47 |
|
365.00K | $3.72M | 0.42% | New | |
| 48 |
|
2.53M | $3.64M | 0.41% | New | |
| 49 |
|
770.23K | $2.98M | 0.34% | Reduce | |
| 50 |
|
290.00K | $2.91M | 0.33% | New | |
FAQ
What did MANGROVE PARTNERS IM, LLC buy in 2024-Q4?
In its 2024-Q4 13F filing, MANGROVE PARTNERS IM, LLC reported 153 equity positions worth $890.05M in aggregate; its largest disclosed positions were LLYVK ($43.29M), ATMU ($43.08M), TEVA ($42.59M).
How large is MANGROVE PARTNERS IM, LLC's portfolio?
MANGROVE PARTNERS IM, LLC reported $890.05M of long equity holdings across 153 positions as of 2024-Q4. Top-10 holdings account for 40.9% of reported value.
What is MANGROVE PARTNERS IM, LLC's investment style?
HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.